Advertisement
BD Biosciences
BD Biosciences

The Scientist

» drug development and culture

Most Recent

image: Opinion: Justice Delayed, Health Denied

Opinion: Justice Delayed, Health Denied

By | June 4, 2012

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

12 Comments

image: Cartographer of Metabolic Pathways Dies

Cartographer of Metabolic Pathways Dies

By | June 4, 2012

A biochemist who mapped the ways in which molecular pathways interact passed away at age 96.

2 Comments

image: Best in Industry, 2012

Best in Industry, 2012

By | June 1, 2012

Whether working for a pharmaceutical giant or a biotech start-up with a unique vision, researchers who responded to this year’s Best Places to Work in Industry survey are translating society’s most pressing scientific needs into a new generation of drugs, research tools, and cutting-edge innovations.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | June 1, 2012

The Aha! Moment, Imagine, Ignorance, and The Age of Insight

0 Comments

image: Book Excerpt from <em>The Mara Crossing</em>

Book Excerpt from The Mara Crossing

By | June 1, 2012

Author Ruth Padel tells the stories of John James Audubon and cellular migration in prose and verse

1 Comment

Contributors

June 1, 2012

Meet some of the people featured in the June 2012 issue of The Scientist.

0 Comments

image: Delivering New Genes

Delivering New Genes

By | June 1, 2012

Gene therapies typically involve the introduction of genetic material into target cells to replace or supplement an existing, usually dysfunctional, gene. 

0 Comments

image: Interfering with Resistance

Interfering with Resistance

By | June 1, 2012

Drug efficacy and resistance mechanisms shine a light on how drugs enter cells, which could facilitate the development of new sleeping-sickness treatments. 

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

Advertisement
INTEGRA
INTEGRA
Advertisement
Life Technologies